WHO-GMP Certified · Exporting to 40+ Countries

Trusted Medicines,
Made in India

VedaCure Pharmaceuticals manufactures 200+ formulations across 8 therapeutic segments. Two WHO-GMP certified facilities. Serving patients in 40+ countries since 2008.

Pharmaceutical manufacturing
200+
Formulations
40+
Export Countries
2
WHO-GMP Plants
₹850 Cr
Revenue (FY24)
About Us

Science · Care · Trust

Founded in 2008 in Visakhapatnam, VedaCure has grown from a single-product company to one of India's fastest-growing pharmaceutical manufacturers. Our two WHO-GMP certified plants produce tablets, capsules, injectables, liquids, ointments, and dry syrups.

We believe affordable medicines shouldn't mean compromised quality. Every batch undergoes 50+ quality checks before release. Our products are trusted by doctors and patients across India, Africa, Southeast Asia, Latin America, and the CIS region.

Read our story →
Manufacturing facility
Manufacturing

World-Class Facilities

Two state-of-the-art manufacturing plants with combined capacity of 10 billion tablets and 500 million capsules annually. Dedicated lines for beta-lactam and non-beta-lactam products.

  • Visakhapatnam: Oral solids, liquids, ointments (120,000 sq ft)
  • Baddi, HP: Injectables, dry syrups, ophthalmic (80,000 sq ft)
  • Automated packaging with serialization & track-and-trace
  • Zero liquid discharge (ZLD) effluent treatment
Explore facilities →

Certifications & Approvals

WHO-GMPISO 9001:2015ISO 14001:2015EU-GMP (EDQM)TGA AustraliaANVISA BrazilFDA (Site Master File)
Partnership

Contract Manufacturing (CDMO)

Partner with us for end-to-end pharmaceutical manufacturing. From formulation development to commercial production, we offer flexible CDMO services for domestic and international clients.

Formulation Development
Analytical Method Development
Stability Studies
Commercial Manufacturing
Regulatory Filing Support
Packaging & Labelling
Learn about CDMO →
Lab research

Partner With VedaCure

Whether you're looking for quality medicines, CDMO services, or distribution partnerships — let's talk.